Use of PD-1 pathway inhibitors among patients with non-small cell lung cancer (NSCLC) and preexisting autoimmune disorders Meeting Abstract


Authors: Leonardi, G. C.; Gainor, J. F.; Azimi, R. S.; Riess, J.; Rizvi, H.; Hellmann, M. D.; Awad, M. M.
Abstract Title: Use of PD-1 pathway inhibitors among patients with non-small cell lung cancer (NSCLC) and preexisting autoimmune disorders
Meeting Title: 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 35
Issue: 15 Suppl.
Meeting Dates: 2017 Jun 2-6
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2017-05-20
Start Page: 469s
Language: English
ACCESSION: WOS:000411932202141
DOI: 10.1200/JCO.2017.35.15_suppl.9081
PROVIDER: wos
Notes: Meeting Abstract: 9081 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Matthew David Hellmann
    411 Hellmann
  2. Hira Abbas Rizvi
    122 Rizvi